173 related articles for article (PubMed ID: 10694585)
41. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
[TBL] [Abstract][Full Text] [Related]
42. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
Gohlke-Bärwolf C
Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
[TBL] [Abstract][Full Text] [Related]
43. [Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berretini M; Musolesi S
G Ital Cardiol; 1997 Mar; 27(3):231-43. PubMed ID: 9244725
[TBL] [Abstract][Full Text] [Related]
44. A comparison between six- and four-week intervals in surveillance of oral anticoagulant treatment.
Pengo V; Barbero F; Biasiolo A; Pegoraro C; Cucchini U; Iliceto S
Am J Clin Pathol; 2003 Dec; 120(6):944-7. PubMed ID: 14671984
[TBL] [Abstract][Full Text] [Related]
45. Quality of oral anticoagulation in patients with atrial fibrillation: a cross-sectional study in general practice.
Neree C
Eur J Gen Pract; 2006; 12(4):163-8. PubMed ID: 17127602
[TBL] [Abstract][Full Text] [Related]
46. Risk of falls and major bleeds in patients on oral anticoagulation therapy.
Donzé J; Clair C; Hug B; Rodondi N; Waeber G; Cornuz J; Aujesky D
Am J Med; 2012 Aug; 125(8):773-8. PubMed ID: 22840664
[TBL] [Abstract][Full Text] [Related]
47. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis.
Abdelhafiz AH; Myint MP; Tayek JA; Wheeldon NM
Clin Ther; 2009 Jul; 31(7):1534-9. PubMed ID: 19695402
[TBL] [Abstract][Full Text] [Related]
48. [Intensity of oral anticoagulant therapy after heart valve replacement].
Stenzinger W
Z Kardiol; 1998; 87 Suppl 4():37-41. PubMed ID: 9857465
[TBL] [Abstract][Full Text] [Related]
49. [Optimizing long-term anticoagulation by patient self-management?].
Bernardo A
Z Kardiol; 1998; 87 Suppl 4():75-81. PubMed ID: 9857471
[TBL] [Abstract][Full Text] [Related]
50. [Hemorrhagic complications and thrombotic phenomena in oral anticoagulation of elderly patients].
Selva O'Callaghan A; San José Laporte A; Fuentes Camps I; Nicolau Fuste J; Piqueras Carrasco J; Vilardell Tarres M
Rev Clin Esp; 1997 May; 197(5):323-8. PubMed ID: 9280965
[TBL] [Abstract][Full Text] [Related]
51. [Hemorrhagic complications from anticoagulant treatment: analysis of predictive risk factors].
Vázquez Ruiz de Castroviejo E; del Monte Trujillo Pérez M; Lozano Cabezas C; Avellaneda Molina C; Guzmán Herrera M; Martínez Galiano E; Pousibet Sanfeliú H; Tarabini Castellani A; Pagola Vilardebó C; Alcalá Muñoz A
Sangre (Barc); 1999 Jun; 44(3):216-21. PubMed ID: 10481584
[TBL] [Abstract][Full Text] [Related]
52. [Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs].
Pengo V; Peruzzi P; Marzari A; Zanon F; Banzato A; Schivazappa L
G Ital Cardiol; 1989 Dec; 19(12):1125-8. PubMed ID: 2561357
[TBL] [Abstract][Full Text] [Related]
53. [International normalized ratio (INR) for optimal anticoagulant therapy].
Uetsuka Y; Katsuki T; Aosaki M; Iwade K; Hashimoto A; Koyanagi H; Saito M; Yaginuma Y; Hosoda S
Kokyu To Junkan; 1993 Sep; 41(9):885-90. PubMed ID: 8210749
[TBL] [Abstract][Full Text] [Related]
54. [Problems of long-term therapy with anticoagulants].
Lechner K; Gaiger A; Fritz A; Kyrle P; Eichinger S; Pabinger I
Acta Med Austriaca; 1992; 19(1):21-4. PubMed ID: 1585783
[TBL] [Abstract][Full Text] [Related]
55. Trial of different intensities of anticoagulation in patients with prosthetic heart valves.
Saour JN; Sieck JO; Mamo LA; Gallus AS
N Engl J Med; 1990 Feb; 322(7):428-32. PubMed ID: 2300106
[TBL] [Abstract][Full Text] [Related]
56. [Interactions between oral anticoagulants and other medication in emergency department--a pharmacoepidemiologic approach].
Apostoae F; Tarţău L; Lupuşoru CE
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):954-60. PubMed ID: 22046815
[TBL] [Abstract][Full Text] [Related]
57. [Anticoagulation in surgery, after hemorrhagic complications and in pregnancy].
Gohlke-Bärwolf C
Z Kardiol; 1998; 87 Suppl 4():56-62. PubMed ID: 9857468
[TBL] [Abstract][Full Text] [Related]
58. [Prevention of thrombosis in heart valve diseases].
Meyer BJ; Beer JH
Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
[TBL] [Abstract][Full Text] [Related]
59. [What can be expected today from long-term anticoagulation for cardiac and arterial thrombosis?].
Loeliger EA
Schweiz Med Wochenschr; 1985 Oct; 115(43):1483-95. PubMed ID: 3909383
[TBL] [Abstract][Full Text] [Related]
60. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
